Kbio

Kbio company information, Employees & Contact Information

Explore related pages

Related company profiles:

KBio aims to create a new generation of biologics using its plant-based platform that has demonstrated the ability to create drug candidates at a fraction of the time and cost of conventional platforms. The Company is focused on developing novel product candidates in two core areas: 1) Antibody therapies for areas of high unmet need; and 2) Pandemic preparedness and response using its plant-based production system to create antibodies and vaccines in shorter timeframes than industry norms. Formed in December 2021, KBio is a subsidiary of BAT with operations in the UK and U.S.

Company Details

Employees
48
Address
Owensboro, Kentucky 42301, Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Owensboro, Kentucky
Looking for a particular Kbio employee's phone or email?

Kbio Questions

News

KBio to close Owensboro facility, resulting in 46 job losses - The Owensboro Times

KBio to close Owensboro facility, resulting in 46 job losses The Owensboro Times

KBio and ZERO Announce Exclusive Strategic Alliance to - GlobeNewswire

KBio and ZERO Announce Exclusive Strategic Alliance to GlobeNewswire

BAT launches plant-based biotech KBio - BioProcess Insider - BioProcess International

BAT launches plant-based biotech KBio - BioProcess Insider BioProcess International

BAT follows tobacco rival Philip Morris into biotech, promising faster R&D with Kbio’s plant-based tech - BioWorld MedTech

BAT follows tobacco rival Philip Morris into biotech, promising faster R&D with Kbio’s plant-based tech BioWorld MedTech

KBio Announces Strategic Partnership with ZabBio to Discover and Develop Antibody Therapeutics - GlobeNewswire

KBio Announces Strategic Partnership with ZabBio to Discover and Develop Antibody Therapeutics GlobeNewswire

LabGenomics USA Completes Acquisition of IMD CLIA Labs - Business Wire

LabGenomics USA Completes Acquisition of IMD CLIA Labs Business Wire

KaloBios Pharmaceuticals, Inc. (KBIO) Stock | Appoints Martin Shkreli CEO - warriortradingnews.com

KaloBios Pharmaceuticals, Inc. (KBIO) Stock | Appoints Martin Shkreli CEO warriortradingnews.com

Help! My short position got crushed, and now I owe E-Trade $106,445.56 - MarketWatch

Help! My short position got crushed, and now I owe E-Trade $106,445.56 MarketWatch

KaloBios (KBIO) Stock | Beginning of the End - warriortradingnews.com

KaloBios (KBIO) Stock | Beginning of the End warriortradingnews.com

KaloBios Pharmaceuticals Inc. ($KBIO) Stock | Files Chapter 11 In Wake Of Shkreli Arrest - warriortradingnews.com

KaloBios Pharmaceuticals Inc. ($KBIO) Stock | Files Chapter 11 In Wake Of Shkreli Arrest warriortradingnews.com

Top Kbio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant